✦ LIBER ✦

The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study

✍ Scribed by Frank Lanza; Bruce Sahba; Howard Schwartz; Steven Winograd; James Torosis; Hui Quan; Robert Reyes; Thomas Musliner; Anastasia Daifotis; Albert Leung

Book ID: 119392081
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 112 KB
Volume: 97
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(01)04008-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of once-monthl

Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study

✍ Ronald Emkey; Pierre D. Delmas; Michael Bolognese; Joao Lindolfo C. Borges; Feli 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi

Safety and tolerability of high doses of

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

✍ R. Ratner; M. Nauck; C. Kapitza; V. Asnaghi; M. Boldrin; R. Balena 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Antiperistaltic effect and safety of l-m

Antiperistaltic effect and safety of l-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study

✍ Naoki Hiki; Michio Kaminishi; Kenjiro Yasuda; Noriya Uedo; Hajime Honjo; Nobuyuk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 712 KB

(210) Results from a phase I, double-bli

(210) Results from a phase I, double-blind, randomized, placebo-controlled, multiple-dose study evaluating the safety, tolerability, and pharmacokinetics of oral doses of NKTR-118

✍ D. Sahner; H. van Paaschen; A. Marcantonio; M. Eldon 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB

S1419: A Phase IIa, Randomized, Controll

S1419: A Phase IIa, Randomized, Controlled, Double-Blind, Dose-Finding Study Evaluating the Safety and Pharmacodynamics of CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy

✍ Dennis S. Riff; Peter J. Winkle; Howard I. Schwartz; James Lees; Karin Wilhelm-O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 217 KB